“ORIDIS Biomarkers – a specialist in tissue based cancer research – is a Contract Research Organisation founded in 2001 as a spin-off from the Medical University of Graz. Based on its unique clinical and biobank network and its sound molecular-pathological expertise ORIDIS Biomarkers designs and performs retrospective and prospective custom made tissue and body fluids based studies.
ORIDIS Biomarkers brings value to its customers by evaluation of the medical and clinical relevance of drug targets, mode-of-action models and biomarker candidates foreseen for patient stratification and diagnosis.
ORIDIS Biomarkers’ unique offering combines its proprietary TISSOMICS™ research platform and proven experience in analysis of clinically relevant tissue with access to a biobank with 2.9 million samples of diseased human tissue and associated data.”
